March 2022

NovoLogix user interface gets upgraded

Starting March 1, 2022, the old version of the NovoLogix^® authorization screen will be deactivated and the new version of the screen will open automatically for all providers. This is part of an upgrade to the NovoLogix user interface.

The new authorization screen has been available since 2020 and most providers are already using it.

Benefits of new authorization screen

The new authorization screen streamlines the process of creating authorization requests. The main features include:

Single-screen authorization entry so you can avoid having to switch screens
Easily collapsible panels, which helps speed up information entry
Summary sections and alerts, which help you review information and check the status of a request

About the NovoLogix tool

The NovoLogix online tool is used to submit prior authorization requests for some medical benefit drugs for Blue Cross Blue Shield of Michigan commercial members, Medicare Plus Blue℠, Blue Care Network commercial and BCN Advantage℠ members.

As a reminder, you can find information about medical benefit drugs that require prior authorization on these webpages at ereferrals.bcbsm.com:

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2021 American Medical Association. All rights reserved.